CORDEN PHARMA Trademark

Trademark Overview


On Friday, August 25, 2023, a trademark application was filed for CORDEN PHARMA with the United States Patent and Trademark Office. The USPTO has given the CORDEN PHARMA trademark a serial number of 79380274. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, May 27, 2024. This trademark is owned by Corden Pharma International GmbH. The CORDEN PHARMA trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceutical products; treatment of chemical products; recycling of chemical products

Pharmaceutical research services; qualitative evaluation of pharmaceutical products; development of pharmaceutical products; inspection of pharmaceutical products; research in the field of pharmaceutical products; testing on pharmaceutical products; pharmaceutical product development services; development of pharmaceutical preparations and medicines; laboratory research services concerning pharmaceutical products; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; provision of information concerning the results of clinical trials for pharmaceutical products; industrial packaging design services; chemical laboratory services; chemical engineering services; chemical analysis; chemical research; testing of chemical products; chemical technology research; analysis of the chemical composition of liquids; evaluation of chemical information to estimate risk levels
corden pharma

General Information


Serial Number79380274
Word MarkCORDEN PHARMA
Filing DateFriday, August 25, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceutical products; treatment of chemical products; recycling of chemical products
Description of MarkThe mark consists of the wording CORDEN PHARMA in blue to the right of a stylized double helix where the left side is blue and the right side is green.
Pseudo MarkCORDEN PHARMACEUTICAL
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical research services; qualitative evaluation of pharmaceutical products; development of pharmaceutical products; inspection of pharmaceutical products; research in the field of pharmaceutical products; testing on pharmaceutical products; pharmaceutical product development services; development of pharmaceutical preparations and medicines; laboratory research services concerning pharmaceutical products; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; provision of information concerning the results of clinical trials for pharmaceutical products; industrial packaging design services; chemical laboratory services; chemical engineering services; chemical analysis; chemical research; testing of chemical products; chemical technology research; analysis of the chemical composition of liquids; evaluation of chemical information to estimate risk levels

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorden Pharma International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, October 5, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 17, 2023APPLICATION FILING RECEIPT MAILED
Friday, April 12, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 22, 2024REFUSAL PROCESSED BY IB
Thursday, May 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 23, 2024ASSIGNED TO EXAMINER
Saturday, April 13, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 26, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 26, 2024REFUSAL PROCESSED BY MPU
Thursday, May 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 23, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 14, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB